Oncoinvent ASA (KLDVK) - Total Assets
Based on the latest financial reports, Oncoinvent ASA (KLDVK) holds total assets worth Nkr507.79 Million NOK (≈ $53.43 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Oncoinvent ASA (KLDVK) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Oncoinvent ASA - Total Assets Trend (2021–2025)
This chart illustrates how Oncoinvent ASA's total assets have evolved over time, based on quarterly financial data. See KLDVK book value for net asset value and shareholders' equity analysis.
Oncoinvent ASA - Asset Composition Analysis
Current Asset Composition (December 2025)
Oncoinvent ASA's total assets of Nkr507.79 Million consist of 29.9% current assets and 70.1% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr0.00 | 2.5% |
| Accounts Receivable | Nkr6.57 Million | 1.3% |
| Inventory | Nkr132.68 Million | 26.1% |
| Property, Plant & Equipment | Nkr0.00 | 0.0% |
| Intangible Assets | Nkr198.43 Million | 39.1% |
| Goodwill | Nkr0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Oncoinvent ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see KLDVK market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oncoinvent ASA's current assets represent 29.9% of total assets in 2025, an increase from 25.9% in 2021.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, up from 0.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 39.0% of total assets, an increase from 37.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 39.1% of total assets.
Oncoinvent ASA Competitors by Total Assets
Key competitors of Oncoinvent ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fujian Wanchen Biotechnology Co. Ltd
SHE:300972
|
China | CN¥10.76 Billion |
|
SLC Agrícola S.A
SA:SLCE3
|
Brazil | R$21.34 Billion |
|
San Miguel AG
BA:SAMI
|
Argentina | AR$664.73 Billion |
|
Inghams Group Ltd
AU:ING
|
Australia | AU$2.26 Billion |
|
Jiangsu Hualv Biological Technology Co.Ltd.
SHE:300970
|
China | CN¥2.55 Billion |
|
Sarawak Plantation Bhd
KLSE:5135
|
Malaysia | RM1.12 Billion |
|
Andfjord Salmon AS
OL:ANDF
|
Norway | Nkr4.52 Billion |
|
Shandong Teamgene Technology Co. Ltd. A
SHG:603151
|
China | CN¥2.92 Billion |
Oncoinvent ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.43 | 2.77 | 3.21 |
| Quick Ratio | 0.69 | 0.27 | 0.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Nkr123.94 Million | Nkr96.67 Million | Nkr125.39 Million |
Oncoinvent ASA - Advanced Valuation Insights
This section examines the relationship between Oncoinvent ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.25 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 5.2% |
| Total Assets | Nkr507.79 Million |
| Market Capitalization | $86.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values Oncoinvent ASA's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Oncoinvent ASA's assets grew by 5.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Oncoinvent ASA (2021–2025)
The table below shows the annual total assets of Oncoinvent ASA from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr507.79 Million ≈ $53.43 Million |
+5.25% |
| 2024-12-31 | Nkr482.47 Million ≈ $50.77 Million |
+12.87% |
| 2023-12-31 | Nkr427.47 Million ≈ $44.98 Million |
+37.22% |
| 2022-12-31 | Nkr311.53 Million ≈ $32.78 Million |
+81.62% |
| 2021-12-31 | Nkr171.53 Million ≈ $18.05 Million |
-- |
About Oncoinvent ASA
Kaldvik AS engages in the salmon farming business in Iceland. It also operates smolt stations. The company was incorporated in 2020 and is headquartered in Eskifjörður, Iceland. Kaldvik AS was formerly known as Ice Fish Farm AS and changed its name to Kaldvik AS in August 2024. Kaldvik AS operates as a subsidiary of Austur Holding As.